DisruptiveBehavior Disorder (DBD) Medication Market by Disease Type (OppositionalDefiant Disorder, Conduct Disorder, and Intermittent Explosive Disorder), byMedication Type (Stimulant, Antipsychotics, Alpha-Agonist, Anticonvulsant, andOthers), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, andOnline Pharmacy), and by Geography (North America, Latin America, Europe, AsiaPacific, Middle East, and Africa) - Size, Share, Outlook, and OpportunityAnalysis, 2018 – 2026
Disruptive behavior disordercomprises a group of disorders including oppositional defiant disorder, conductdisorder, and intermittent explosive disorder. It usually affects young peoplebelow 18 years of age. Children/teenagers suffering from this disorder areunable to regulate her/his emotions and behaviors, act defiant, and are inconflict with other peers in surrounding thereby facing low quality of life athome, school, or both. Various causes of DBD include child abuse or neglect, atraumatic life experience, such as sexual abuse or violence, and a familyhistory of DBDs. DBDs can be treated with variety of option, initiated withpsychological therapy. Under psychological therapy, counselling and guidance isprovided either to parent or child alone, or family together, to improveresponse to incidence of DBDs. Medication treatment is preferred either incombination with psychological treatment or started when psychological therapyproves to be insufficient.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2390
Disruptive Behavior Disorder MedicationMarket - Market Dynamics
Major factors responsible forgrowth of the disruptive behavior disorder medication market are rising burdenof the disruptive behavior disorders worldwide, increasing awareness amongstparent about this disorder, and improvement of psychotic and medicationtreatment. According to a study published in the journal BMJ Open (Matthew DBurkey et al) in 2015, oppositional defiant disorder (ODD) and conduct disorder(CD) had an estimated worldwide prevalence of 3.3% and 3.2%, respectively.World Health Organization in its 2016 factsheet stated that globally, 7.4 % ofdisability-adjusted life years (DALYs) are caused by disorders in mental andbehavioral disorders category.
Disruptive Behavior DisorderMedication Market - Regional Insights
On the basis of geography,disruptive behavior disorder medication market is segmented into North America,Latin America, Europe, Asia Pacific, Middle East, and Africa. North America isexpected to be the leading region in the disruptive behavior disordermedication market during forecast period. According to statistics given byAgency for Healthcare Research and Quality in 2016, 3 out of every 100 childrenin the U.S. are affected by disruptive behavior disorder, it affects morenumber of boys than girls and is common among children aged 12 years and older.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/disruptive-behavior-disorder-dbd-medication-market-2390
‘Speak Up for Kids’ campaign isan education and outreach initiatives by Child Mind Institute (U.S. basednon-profit organization), through which awareness about mental health issuesand needed information is provided to families, educators, the media, andpolicymakers. Various medical centers and hospitals such as Arkansas ValleyBehavioral Health System have established dedicated resources for treatment ofdisruptive behavior disorder.
Disruptive Behavior DisorderMedication Market - Competitive Landscape
Key players present in thedisruptive behavior disorder medication market are Promius Pharma LLC, ShirePLC, Johnson and Johnson, Mylan N.V., Novartis AG, Teva PharmaceuticalsIndustries Ltd., GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., LupinLtd., and Eli Lilly and Company.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2390
About CoherentMarket Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
